Add time:09/08/2019 Source:sciencedirect.com
The present proof-of-concept study reports the construction of a whole-cell biocatalyst for the de novo production of ω-hydroxy Octanoic acid (cas 124-07-2). This was achieved by hijacking the natural fatty acid cycle and subsequent hydroxylation using a specific monooxygenase without the need for the additional feed of alkene-like precursors. For this, we used the model organism Escherichia coli and increased primarily the release of the octanoic acid precursors by overexpressing the plant thioesterase FatB2 from Cuphea hookeriana in a β-oxidation deficient strain, which lead to the production of 2.32 mM (8.38 mg gcww−1) octanoic acid in 24 h. In order to produce the corresponding ω-hydroxy derivative, we additionally expressed the engineered self-sufficient monooxygenase fusion protein CYP153AMaq(G307A)-CPRBM3 within the octanoic acid producing strain. With this, we finally produced 234 μM (0.95 mg gcww−1) ω-hydroxy octanoic acid in a 20 h fed-batch set-up.
We also recommend Trading Suppliers and Manufacturers of Octanoic acid (cas 124-07-2). Pls Click Website Link as below: cas 124-07-2 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View